Patient | Primary culture | 1st line therapy | 1st line response (3 cycle) | 1st line response (6 cycle) | 2nd line therapy | 2nd line response (3 cycle) |
---|---|---|---|---|---|---|
#1 | PE g/11 | Cis + Vin | PR | SD | Erlotinib | PD |
#2 | PE n/11 | Cis + Vin | PD | |||
#3 | PE p/11 | Cis + Gem | SD | SD | Pemetrexed | PD |
#4 | PE r/11 | Cis + Gem + Beva | PR | |||
#5 | PE s/11 | Cis + Taxotere | PR | |||
#6 | PE u/11 | Cis + Gem + Beva | PR |